Growth factors: Bioactive macromolecular drugs for peripheral nerve injury treatment – Molecular mechanisms and delivery platforms

Bioactive macromolecular drugs known as Growth Factors (GFs), approved by the Food and Drug Administration (FDA), have found successful application in clinical practice. They hold significant promise for addressing peripheral nerve injuries (PNIs). Peripheral nerve guidance conduits (NGCs) loaded wi...

Full description

Bibliographic Details
Main Authors: Teng Wan, Feng-Shi Zhang, Ming-Yu Qin, Hao-Ran Jiang, Meng Zhang, Yang Qu, Yi-Lin Wang, Pei-Xun Zhang
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222301822X